07.27.23 -- A Patient- And Planet-Centric Approach To Enhancing Medicines In Development

As pharmaceutical patients take an increasingly active role in their own health, it is essential to promote better adherence, improve medical benefits, and bolster market perception of your drug product. Explore the evolving technologies enabling this shift toward improved quality of life and the potential of nanotechnology to aid this transition.

Glioblastoma multiforme (GBM) is the most common type of malignant primary brain tumor. It is difficult to treat and has a high risk of recurrence after surgery, placing efficacious treatments in high demand. Discover new possibilities for increased dosing capabilities and diffusion across the brain parenchyma offered by nanoformed APIs.

Christian Jones, CCO of Nanoform, discusses what it truly means to be patient-centric in the modern pharmaceutical industry. Discover the challenges pharma companies are facing as they switch focus as well as the actions and technologies companies are implementing to help achieve a brighter future for patients.